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T
itin is the third most abundant protein
in sarcomeres and fulfills a number
of mechanical and signaling functions.
Specifically, titin is responsible for most of
the passive forces in sarcomeres and the
passive visco-elastic behaviour of myofibrils
and muscles. It has been suggested, based on
mechanical testing of isolated titin molecules,
that titin is an essentially elastic spring if
Ig domain un/refolding is prevented either
by working at short titin lengths, prior
to any unfolding of Ig domains, or at
long sarcomere (and titin) lengths when Ig
domain un/refolding is effectively prevented.
However, these properties of titin, and
by extension of muscles, have not been
tested with titin in its natural structural
environment within a sarcomere. The
purpose of this study was to gain insight
into the Ig domain un/refolding kinetics
and test the idea that titin could behave
essentially elastically at any sarcomere length
by preventing Ig domain un/refolding during
passive stretch-shortening cycles. Although
not completely successful, we demonstrate
here that titin?s visco-elastic properties
appear to depend on the Ig domain
un/refolding kinetics and that indeed, titin
(and thus myofibrils) can become virtually
elastic when Ig domain un/refolding is
prevented. Keywords: skeletal muscle, titin,
actin, myosin, stretch-shortening cycles, passive
properties, stiffness, elastic, visco-elastic, energy
loss, hysteresis, muscle properties, cross-bridge
theory, sliding filament theory, sarcomere, sarcomere
mechanics.
Introduction
When a muscle is stretched to a certain threshold
length (which differs between muscles), it starts to
exhibit passive forces that increase non-linearly with
increasing muscle lengths 1−3. These passive forces
are caused primarily by collagen fibrils embedded
into the muscles connective tissues and by the
structural protein titin, the third most abundant
protein in sarcomeres 4−6. While the connective
tissues and associated collagen fibrils are (visco-)
elastic structures with predictable properties, titins
properties are not nearly as predictable. Titin
contributes to force regulation in actively stretched
muscle by changing its stiffness through binding of
calcium at specific sites 7−9 and is thought to change
its free spring length by binding or interacting with
actin 10−14. During passive stretching, the various
domains of titin are successively engaged 15 and give
rise to the changing passive properties observed in
myofibrils 16.
15
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Figure 1:
Schematic drawing of a sarcomere with the contractile proteins actin and myosin, and the structural protein titin.
Titin spans the half-sarcomere from the M-line in the middle of the sarcomere to the Z-line at the ends of the
sarcomere. It is fixed to myosin and is inextensible in the A-Band region, but acts as a molecular spring in the I-Band
region. Its primary spring elements are the proximal and distal Ig domains (schematically indicated by the blue circles
close to the Z-line and the A-Band, respectively and the PEVK region separating the two Ig domains adapted from
[17], with permission).
Titin (also called connectin) is a sarcomeric protein
that spans the half sarcomere from the M-line to
the Z-line 5−6,18 (Figure 1). It produces most of
the passive force within the contractile unit, the
sarcomere 19−20, provides stability to the thick
(myosin) filament in the centre of the sarcomere
21−22, contributes to the residual force enhancement
observed in muscles following active stretching 8,23−24,
is responsible for force regulation in actively stretched
muscles 25−26, and provides stability for serially
arranged sarcomeres on the descending limb of the
force-length relationship 27−28. Titin acts like a
spring in its extensible I-Band region. At short
sarcomere lengths and small passive forces, the
immunoglobulin (Ig) domains of titin are thought
to align. With increasing sarcomere lengths, the
so-called PEVK region, named so for its abundance
in proline (P), glutamate (E), valine (V), and lysine
(K) residues, is thought to become stretched, while
at very long lengths, the Ig domains start to unfold
15.
Exploring the passive mechanical properties of titin
has been difficult, as isolation of this giant protein
has proven tricky, and the individual domains of
titin have vastly differing properties 30−31. However,
Kellermayer et al. 29,32 were able to isolate single
titin molecules and test their mechanical properties
using a laser trap approach. By attaching a bead
to one end of titin that could then be trapped using
a laser, and by fixing the other end of titin rigidly,
they performed stretch-shortening experiments of
different magnitudes, thereby exploring the properties
of titin when different regions became recruited
during stretch. Kellermayer et al. 29,32 observed
that single titin molecules behaved essentially elastic
below a stretch force of approximately 25pN but
highly viscoelastic above 25pN (Figure 2). However,
if the stretch-shortening cycles were repeated, the
hysteresis of the force-elongation/shortening curves
became smaller, and if stretch-shortening cycles
were restricted to long lengths (and high passive
forces) where Ig domain unfolding and refolding
was essentially abolished, titin was shown to exhibit
virtually elastic properties with little or no hysteresis
32. They argued that if titin was completely unfolded,
and refolding of Ig domains was prevented during
cyclic stretch shortening cycles, titin would act as an
elastic spring, while it would behave viscoelastic if
un/refolding of Ig domains was allowed. Since large
hystereses in stretch-shortening cycles are associated
with great losses of energy, it would be of distinct
advantage if such losses were minimized in working
muscles.
Kellermayer et al.29 found that titin forces need
to be very small (<2.5pN) for effective Ig domain
refolding, and we demonstrated that even in the
16
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Figure 2:
Force-elongation curves for isolated titin molecules stretched using a laser tweezer approach 29. Titin shows an
inflection point (c) at the point where Ig domain unfolding is supposed to occur, and shows a great hysteresis when
stretched and shortened beyond point (c). Below length (c), titin behaves essentially elastic (inset short length).
Similarly, titin also behaves virtually elastic at long length (inset long length), but only if stretch-shortening occurs
without appreciable unfolding and refolding of Ig domains (adapted from Kellermayer et al. 1997, with permission).
absence of measurable force, titin refolding remained
incomplete even after as long as ten minutes in
single myofibrils of rabbits when held at average
sarcomere lengths of 2.6 µm [16]. These results
suggest that stretching of titin easily unfolds Ig
domains, while shortening does not readily allow for
refolding 33, thus, in repeat stretch-shortening cycles
titin becomes increasingly more elastic and loss of
energy is minimized. Therefore, we hypothesized
that titin is a (visco-) elastic spring that can change
its domain of virtually elastic behaviour to any
sarcomere lengths of repeated use if Ig domain
un/refolding is prevented.
The purpose of this study was to test if titin
behaves essentially elastic at long lengths where
effective un/refolding of Ig domains is prevented,
thereby testing Kellermayers ideas for the first time
with actin in its proper structural environment.
Furthermore we wanted to test if the rate of refolding
of Ig domains, in the absence of force, is sarcomere
length dependent. All experiments were performed
using isolated myofibrils from rabbit psoas muscle,
which allows for accurate determination of the
mechanical properties of titin in its native structural
arrangement 16,33
Methods
Preparation: Myofibrils were prepared for mechanical
testing as outlined previously by our group 8,16,25,34.
Briefly, myofibrils were obtained from psoas muscles
of New Zealand White rabbits, and were chemically
and mechanically isolated to form single fibrils with
serially arranged sarcomeres. Isolated myofibrils were
then immersed into a bath on top of an inverted
microscope in a rigor solution (see solutions below).
After ten minutes of stabilization, the rigor solution
was replaced with a low calcium relaxation solution
(see solutions below) that prevented any active
actin-myosin based-cross bridge forces 8. Myofibrils
in suspension were then washed away, leaving those
attached to the bottom cover glass. Myofibrils
of appropriate length (typically 6-12 sarcomeres in
series) that showed distinct striation patterns were
then selected for mechanical testing by attaching
them at one end to a silicon nitride lever for force
measurements (stiffness of 68pN/nm, force resolution
of 0.5nN, and spatial resolution of 7nm) and at
the other end to a rigid glass needle attached to a
motor for controlled, sub-nanometre step size, length
changes (Fig. 3). Three distinct experiments were
performed as outlined below.
The image of the attached myofibrils was
projected onto a high density photo diode array
(Schafter/Kirschoff, Hamburg, Germany, resolution of
7nm) for identification of the A- and I-bands, z-lines,
and the calculation of sarcomere lengths from z-line
to z-line or between the centroids of adjacent A-bands
if z-lines were not clearly visible.
Solutions: The rigor solution (pH 7.4) was
composed of (in mM): 50 Tris, 100 NaCl, 2 KCl, 2
MgCl2, and 10 EGTA. Protease inhibitors were added
to the final solution, in the following concentrations
(in pM): 10 leupeptin, 5 pepstatin A, 0.2 PMSF, 0.5
17
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Figure 3:
Myofibril set up for mechanical testing. A myofibril with approximately 30 sarcomeres is attached at its right end to a
rigid glass needle, which in turn is attached to a motor with less than nm step resolution for imposing computer
controlled stretch-shortening cycles. The left end of the myofibril is attached to one of a pair of nano-levers for force
measurements. Upon force production the myofibril will pull the attached lever away from its reference lever, and
knowing the stiffness of the lever (68pN/nm in this case), instantaneous forces can be determined with a resolution of
less than 0.5nN. For reference, myofibrils are approximately 0.7-1.0µm in diameter and sarcomeres shown here have an
average length of approximately 2.2µm.
N, and 0.5 DlT. The relaxing solution (pH = 7.0;
pCa2 = 8) was composed of (in mM): 10 MOPS, 64.4
K+ proprionate, 5.23 M proprionate, 9.45 Na2SO4,
10 EGTA, 7 ATP, 10 creatine phosphate. Note
specifically that the low calcium concentration of
the relaxing solution did not permit any actin-myosin
based active force production during the experiments
8,25,35.
Protocol: Experiment 1 : Myofibrils (n=8) were
passively stretched 8 from a nominal initial average
sarcomere length of about 2.6µm by nominal amounts
of 2.0, 2.5, and 3.0 µm/sarcomere at a speed of
0.1µm/s/sarcomere 16 and then released at the same
speed to the starting length. Three consecutive
stretch-shortening cycles were performed without
rest, followed by one or two subsequent sets of three
stretch-shortening cycles separated by a ten minute
rest at an average sarcomere length of 2.6µm.
Experiment 2 : Using separate myofibrils (n=8), the
testing protocol described in the previous paragraph
was repeated with the exception that myofibrils were
rested for ten minutes between sets at an average
sarcomere length of 1.8 µm (instead of 2.6µm used in
the first protocol). Note that neither resting length
was associated with a measurable passive force.
Experiment 3 : Finally, another set of myofibrils
(n=5) was stretched passively from an average
sarcomere length of 2.6µm by a nominal amount
of 2.0µm/sarcomere at a speed of 0.1µms/sarcomere.
When the final stretch length was reached, myofibrils
were subjected to ten stretch-shortening cycles of
nominal magnitude 0.5, 1.0, or 1.5µm per sarcomere,
and then, following the last of these cycles, released
to the starting length. In contrast to the first two
experiments where at least partial re-folding of Ig
domains was expected during myofibril shortening,
in these last set of experiments, Ig domain re-folding
was not expected to occur because of the length of
titin during the repeat stretch-shortening cycles and
the significant amount of force 29,32−33.
Analysis: The primary outcome measures in
this study were the peak forces obtained in the
stretch shortening cycles, the loading energies of all
stretch cycles, the hysteresis for the three repeat
stretch-shortening cycles of experiments 1 and 2, and
the peak forces, loading energies, and hysteresis for
the ten stretch-shortening cycles of 0.5µm amplitude
in experiment 3. Loading energies were calculated as
the integral of the force-elongation curves during the
loading phase. Unloading energies were calculated as
the integral of the force-elongation curves during the
unloading phase. Hystereses were calculated as the
loading minus the corresponding unloading energy in
a stretch-shortening cycle.
The primary statistical analyses that were
performed included comparisons of the anticipated
18
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Figure 4:
Exemplar stretch-shortening cycles of a single myofibril stretched from an initial average sarcomere length of about
2.6µm. (A) Stretch 1 is the first stretch-shortening cycle of set 1, while stretch 2 is the first stretch-shortening cycle of
set 2 which occurred after a ten minute rest period with the myofibril relaxed at an average sarcomere length of 2.6µm.
Note that the peak force and loading energy is substantially decreased in stretch 2 compared to stretch 1, indicating
incomplete recovery, and thus incomplete refolding of Ig domains in the ten minute rest period. (B) Stretch 1 is the
third stretch-shortening cycle of set 1, while stretch 2 is the first stretch-shortening cycle of set 2 which occurred after
a ten minute break with the myofibril relaxed at an average sarcomere length of 2.6µm. Note the similarity in loading
energy and peak force between the first stretch of set 2 and the last stretch of set 1, suggesting that there was little (if
any) recovery of passive force in the ten minute rest period at a sarcomere length of 2.6µm. indicating little or no
refolding of Ig domains in the break. Forces on the left axes are the measured myofibril forces (nN) while forces on the
right axes represent an estimate of the forces in a single titin molecule (pN) assuming 2700 titin molecules per µm2.
decrease in peak forces, loading energies, and
hysteresis for the three repeat stretch-shortening
cycles, the recovery of peak force and hysteresis after
the ten minute rest at average sarcomere lengths
of 2.6µm (experiment 1) and 1.8µm (experiment 2),
and the decrease in peak force, loading energies, and
hysteresis in the ten repeat shortening-stretch cycles
of 0.5µm amplitude at the long sarcomere lengths of
experiment 3. All values are given as means ±1SE,
and changes in outcome measures between repeat
stretch-shortening cycles (either with or without
break) were assessed using non-parametric Friedmans
repeated measures testing 36 with a=0.05.
Results
Experiment 1 : Peak forces during the stretch
shortening cycles were reduced significantly (p<0.05)
by 16% and 11% for cycles 1, 2, and insignificantly
for cycle 3 (3%), respectively of set 2 compared to the
corresponding cycles in set 1 (Fig. 4A). Furthermore,
the peak forces of the 1st cycle of the second set were
similar (109±26nN) to the peak forces of the 3rd cycle
of the first set (112±26nN), indicating that there was
no significant force recovery in the 10 minute rest
period between sets, when myofibrils were rested
at an average sarcomere length of 2.6µm (Fig. 4B).
Similarly to the peak forces, the loading energies were
reduced significantly (p<0.05) by 30% and 13% for
cycles 1, 2, but not for cycle 3 (0%), respectively of set
2 compared to the corresponding cycles in set 1 (Fig.
4A). Also, the loading energies of the 1st cycle in the
2nd set were similar (86±25nNµm) to the 3rd cycle
in the first set (78±18nNµm), indicating that there
was no substantial recovery of loading energy in the
10 minute rest period between sets, when myofibrils
were rested at an average sarcomere length of 2.6µm
(Fig. 4B). The energy loss (hysteresis) expressed
relative to the corresponding loading energies were
the same for the first and second sets and averaged
60, 53, and 48% for cycles 1, 2, and 3, respectively.
Experiment 2 : In contrast to experiment 1, the
peak forces during the stretch-shortening cycles were
not reduced between the first and second set of
stretch-shortening cycles in experiment 2 (Fig. 5A).
In fact, peak forces in the second set tended to be
slightly (but not significantly) higher by 8%, 7%,
19
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Figure 5:
Exemplar stretch-shortening cycles of a single myofibril stretched from an initial average sarcomere length of about
2.6µm. (A) Stretch 1 is the first stretch-shortening cycle of set 1, while stretch 2 is the first stretch-shortening cycle of
set 2 which occurred after a ten minute rest period with the myofibril relaxed at an average sarcomere length of 1.8µm.
Note that the peak force and loading energy are essentially the same, indicating complete recovery, and thus complete
refolding of Ig domains in the ten minute rest period. (B) Stretch 1 is the third stretch-shortening cycle of set 1, while
stretch 2 is the first stretch-shortening cycle of set 2 which occurred after a ten minute break with the myofibril relaxed
at an average sarcomere length of 1.8µm. Note the substantial increase in loading energy and peak force in the first
stretch of set 2 (purple) compared to the last stretch of set 1 (yellow), suggesting a big recovery of passive force in the
ten minute rest period at a sarcomere length of 1.8µm, indicating substantial refolding of Ig domains in the rest period.
Forces on the left axes are the measured myofibril forces (nN) while forces on the right axes represent an estimate of
the forces in a single titin molecule (pN) assuming 2700 titin molecules per um2.
and 7% respectively for cycles 1, 2, and 3 compared
to the corresponding peak forces in the first set.
Consistent with these results, the peak forces in the
1st cycle of the second set were significantly higher
(p<0.05) (107±11nN) than the peak forces in the
3rd cycle of the first set (92±11nN), indicating a
susbstantial recovery of force when myofibrils were
rested for ten minutes at an average sarcomere length
of 1.8µm (Fig. 5B). Although the loading energies
were slightly reduced in the second set by 11%, 4%,
and 4% for cycles 1, 2, and 3, respectively, only the
values for the first cycle were statistically different
(Fig. 5A). In agreement with the peak forces, the
loading energy of the 1st cycle in the second set
was significantly (p<0.05) higher (79±8nNµm) than
the loading energies of the 3rd cycle in the first set
(51±6nNµm), thereby indicating a great recovery
of loading energy in the ten minute rest period
when myofibrils were held at an average sarcomere
length of 1.8µm (Fig. 5B). Energy losses (hysteresis)
relative to the loading energies were the same for the
corresponding stretch-shortening cycles in the first
and second set and averaged 68, 49, and 45% for
cycles 1, 2, and 3, respectively, values similar to those
obtained in experiment 1.
Experiment 3 : The loss in peak force across the ten
repeat stretch-shortening cycles at long sarcomere
lengths was 11
Most importantly, however, the hystereses observed
in experiments 3 were much smaller than in
experiments 1 and 2 and ranged from 5nNµm (for
cycle 1) to 1nNµm (for cycle 10) with an average
value of 3nNµm, compared to 72 nNµm (cycle
1, experiment 1) to 37nNµm (cycle 3, experiment
1), and 61 nNµm to 23nNµm, for cycle 1 and 3,
respectively of experiment 2. However, the absolute
hysteresis might not be good for comparison, since
the stretch-shortening amplitude affects these values.
However, by expressing the hysteresis (energy loss)
in terms of the loading energy provides an indication
of the energy loss in the different experiments.
The energy loss (hysteresis) relative to the
loading energies averaged 14%, 14% and 27% for
stretch-shortening amplitudes of 0.5, 1.0 and 1.5µm,
respectively, with the highest value of 34% (1st cycle
for 1.5µm amplitude) and the smallest value of 8%
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(cycles 7-10 for 0.5µmm amplitude). These values are
all much smaller than the corresponding values given
above for experiments 1 (48-60%) and 2 (45-68%),
indicating a much more elastic (less energy loss)
response. The smallest energy loss values of 8% are
similar to those obtained for tendinous materials [37].
Discussion
Titins I-band regions act as a molecular spring
15, providing most of the passive force in isolated
sarcomeres 8,23 and myofibrils 8,23,33,35. Titin consists
of several spring regions with different properties
arranged in series 15,29−32: the proximal Ig domain,
the N2A and PEVK domains, and the distal Ig
domain. While studying isolated titin molecules using
a laser tweezer approach, Kellermayer and colleagues
29 discovered that titin acted virtually elastically
for stretch-shortening cycles corresponding to short
sarcomere lengths and forces below approximately
25pN (Fig. 2), and at lengths corresponding to long
sarcomeres where Ig domains were assumed to remain
permanently unfolded 29,32. However, when titin was
pulled to lengths beyond Ig domain unfolding, it
showed a large hysteresis with a corresponding great
loss of energy in the stretch-shortening cycle. These
results by Kellermayer et al. 29,32suggest that titin
can act as a virtually elastic spring, if Ig domain
unfolding and refolding is prevented. Such situations
could occur at very short sarcomere lengths, prior to
any Ig domain unfolding 33, and at long sarcomere
lengths if Ig domain un/refolding is prevented.
Since it appears impossible to have all Ig domains
unfolded within physiologically relevant sarcomere
lengths 16,29,33, the elastic region of titin can
potentially be shifted to different sarcomere lengths,
by pre-unfolding titin Ig segments permanently in
cyclic movements over a given range of sarcomere
lengths.
However, these theoretical considerations, and
experimental findings on isolated titin molecules
have never been tested systematically for titin in
their native and structurally correct environment
of a sarcomere, although detailed analysis of titins
properties at sarcomere lengths below which Ig
domain unfolding occurs (3.0-3.5µm) in rabbit psoas
muscles - 16,29 have been made 33. Therefore,
the purpose of this study was to test under what
conditions Ig domain refolding occurs in sarcomeres,
and if there is indeed a virtually elastic region of
passive sarcomere stretch-shortening cycles when
Ig domain refolding is prevented at long sarcomere
lengths. Experiments were performed using isolated
myofibrils from rabbit psoas muscles which have been
shown to have passive forces that originate almost
exclusively from titin, and represent titin properties
well 16,33.
We would like to emphasize two major results
obtained in this study. The first is that after ten
minutes of recovery, peak forces and loading energies
did not recover substantially when myofibrils were
rested at an average sarcomere length of 2.6µm (Figs
4A and B), but peak forces and loading energies
recovered almost completely when myofibrils were
rested at an average sarcomere length of 1.8µm
(Figs. 5A and B). These findings suggest that in
the ten minute recovery between stretch-shortening
sets, unfolded Ig domains were able to refold at
sarcomere lengths of 1.8µm but not at sarcomere
lengths of 2.6µm. There is no passive force in psoas
myofibrils at sarcomere lengths of 2.6µm or less,
thus forces in titin would be zero too. This result
suggests, that in contrast to isolated experiments in
titin 29, and previous work in rabbit psoas myofibrils
33 spontaneous refolding of Ig domains does not
necessarily occur when forces in titin become low
(less than about 2-3pN 29,32), but requires sarcomere
lengths, and thus titin lengths, to be short as well
for effective refolding. The threshold length for Ig
domain refolding to occur effectively lies somewhere
between 2.6 and 1.8µm (for rabbit psoas), but cannot
be narrowed down at present as only observations
from these two resting lengths are available.
When no rest was given between stretch-shortening
cycles, peak forces, loading energies, and hysteresis
decreased from cycles 1-3 in experiments 1 and 2,
indicating that Ig domains remained permanently
unfolded after the first cycle, thereby providing a
more elastic response with increasing cycle number.
This property has been observed in a previous study
on isolated myofibrils 16,33 and is consistent with
observations on isolated titin molecules 29,32.
The second result to be emphasized is the virtually
elastic behaviour of myofibrils in the last few
stretch-shortening cycles of experiment 3, in which
effective Ig domain un/refolding was prevented by the
experimental protocol design (Fig. 6). Experiment
3 was designed to minimize Ig domain refolding for
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Figure 6:
Force-sarcomere length (A) and force-time relationships (B) for an exemplar myofibril in experiment 3. The myofibril
was stretched from an initial length of approximately 2.7µm/sarcomere to a final length of about 4.2µm/sarcomere
followed by ten repeat shortening-stretch cycles of small magnitude (note the last cycle is only half the magnitude of
the previous cycles). There is a small loss of peak force in the ten repeat stretch-shortening cycles indicating
visco-elastic creep. Note the virtually elastic behaviour for the ten repeat stretch-shortening cycles at long sarcomere
lengths where (some) Ig domains are unfolded. The left inset shows the first of the ten stretch-shortening cycles, the
right inset the tenth one. In the left inset, the shortening (yellow) is matched by the subsequent stretch (blue) curve
for the low force values (50-90nN) but then the stretch curve (blue) falls off to longer length. This behaviour suggests
that there was no effective refolding of Ig domains, but that towards the end of the stretch, additional Ig domains
became unfolded, causing the slight decrease in peak force and increased length. In the right inset (tenth full cycle),
the red (shortening) and blue (stretching) curves essentially overlap, thereby displaying an essentially elastic response,
suggesting that effective unfolding and refolding of Ig domains was prevented. This is in stark contrast to the big
hysteresis (and energy loss), when the myofibril is returned to its original (2.7µm) length. Forces on the left axes are
the measured myofibril forces (nN) while forces on the right axes represent an estimate of the forces in a single titin
molecule (pN) assuming 2700 titin molecules per µm2.
stretch-shortening cycles at long sarcomere lengths
where Ig domains were known to have unfolded in
the first stretch cycle. Experiments for all three
magnitudes of stretch-shortening cycles (0.5, 1.0
and 1.5µm) at these long sarcomere lengths showed
substantially less energy loss (hysteresis) relative to
the loading energies, than stretch-shortening cycles
in experiments 1 and 2. This finding suggests that
titin can act almost elastically at long lengths, if Ig
domain refolding is prevented, thereby minimizing
energy loss for repeat passive motion. The sarcomere
lengths where this virtually elastic behaviour can be
22
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elicited can vary, as it merely requires that the Ig
domains within the range of the stretch-shortening
cycle remain permanently unfolded. This range
of sarcomere lengths can vary, as the number of
permanently unfolded Ig domains determines at what
lengths elastic behaviour is observed.
The reason why the stretch-shortening cycles
of experiment 3, even after ten repeat cycles
were not perfectly elastic (there remained a tiny
hysteresis of about 8%), is likely associated with
the time-dependent unfolding of Ig domains 7,38,39.
Ig domain unfolding does not only depend on the
force acting on titin and its Ig domains, but is also a
stochastic process, in which the energy barrier for Ig
domain unfolding can be exceeded even in the absence
of high external forces. Since our stretch-shortening
cycles were performed at a slow speed (0.1µm/s per
sarcomere) a stretch-shortening cycle of 0.5µm/s
per sarcomere takes 10s to complete, which is
ample time for Ig domains to unfold. We predict
however, that if our experiments had been done at
a greater speed (lets say 1µm/s per sarcomere), the
hysteresis observed in experiment 3 would have been
essentially abolished giving a virtually elastic passive
behaviour of the myofibrils. Another way to test
the idea of stochastic unfolding of Ig domains in the
stretch-shortening experiments of experiment 3 would
be to stretch myofibrils to the initial long lengths,
but then allow the myofibrils to stress relax to allow
for time-dependent unfolding of Ig domains to occur.
Starting the ten repeat stretch-shortening cycles after
such stress relaxation should give an essentially elastic
behaviour of passive myofibrils as all Ig domains
would be unfolded (in the ideal experiment) and
no refolding could occur as force and sarcomere
length are too high for refolding to occur. This last
experiment would essentially mimic the approach by
Kellermayer and colleagues 32 where they stretched
isolated titin molecules to such long lengths that all
Ig domains were unfolded. Shortening from such long
lengths then revealed an essentially elastic behaviour
of titin. Unfortunately, such an experiment cannot be
performed with titin in situ, as the stretch required
for all Ig domains of titin to unfold, would go beyond
the failure lengths of intact sarcomeres 40. However,
increasing the stretch-shortening speed, and achieving
(near) complete Ig domain unfolding with a stress
relaxation test at long sarcomere lengths, should
allow for testing the changing mechanical properties
of titin.
A secondary result of potential importance is the
fact that stiffness of titin changes as a function of the
history of loading. For example, in Fig. 6, stiffness
of titin for the first stretch cycle from 2.7-4.2µm is
substantially smaller than the stiffness observed in
the ten repeat stretch shortening cycles, as can be
seen by the slope of the force-sarcomere length curves.
Therefore, it appears that not only titins visco-elastic
properties but also its stiffness at a given (sarcomere-)
length can change substantially and affect the
instantaneous passive properties of muscle. In
summary, our results suggest that titin is a molecular
spring with high visco-elasticity and associated energy
loss during passive stretch-shortening cycles when Ig
domain unfolding and refolding is allowed to occur.
However, at lengths prior to Ig domain unfolding
(average sarcomere lengths of about 3.0-3.5µm for
rabbit psoas) 16,29, or at lengths after Ig domain
unfolding has occurred (3.5µm) but Ig domain
refolding is prevented, titin can act as an essentially
elastic spring, thereby minimizing energy losses in
passive stretch-shortening cycles. Since not all
Ig domains will ever be unfolded within feasible
sarcomere lengths, it appears that the region of
near-elastic behaviour can be adapted to any lengths
for repeat stretch-shortening cycles if Ig domain
refolding is prevented either by the speed of the
stretch-shortening cycles or by the length of the
sarcomeres.
Titins properties are known to vary with activation
because of calcium binding, phosphorylation and
titin-actin interaction in active muscle 13,14,27,41−45.
It will be important to elucidate the detailed
behaviour and properties of titin in stretch-shortening
cycles while activated. However such experiments are
infinitely more difficult to perform than the passive
experiments presented here, as one must distinguish
between the time dependent cross-bridge forces and
titin forces contributing to the total force in activated
preparations.
In conclusion, we suggest that titin is a molecular
spring whose (visco-) elastic properties and stiffness
are governed by the unfolding/refolding kinetics of
the Ig domains, and that the elastic behaviour of titin
can shift to the required working range for repeat
stretch-shortening cycles.
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